National Coverage Determination 200.3: Monoclonal Antibodies for the Treatment of Alzheimer's Disease
Published 06/17/2024
Make sure your billing staff knows about: FDA-approved monoclonal antibodies, criteria for coverage, coding information, and claims processing instructions.